top
Search terms
Results 1 - 4 of 4 - ordered by :
Escardio

Doctor Jonathan Emberson, University of Oxford British Heart Foundation Senior Statistician, notes, “Statin therapy had no adverse effect on cancer at any site or in any group of individuals, ...

Date : 20/08/2010
Escardio

Inclisiran—an investigational drug that “switches off” PCSK9 synthesis in the liver—lowers rates of low-density lipoprotein (LDL) cholesterol for up to one year in patients ...

Date : 29/08/2017
Escardio

Skin cancer is particularly common, but solid organ cancers including colorectal cancer, prostate cancer and lymphoma also occur. The increased rate of cancer in heart transplant recipients may be ...

Date : 20/05/2012
Escardio

Anacetrapib, an inhibitor of cholesteryl ester transfer protein (CETP) activity, lowers the risk of heart attack and related cardiovascular complications in patients receiving intensive statin ...

Date : 29/08/2017